Tocagen Inc. Sustainability Profile
Tocagen Inc., a pioneering biotechnology company headquartered in the United States, focuses on developing innovative cancer therapies. Founded in 2013, Tocagen has made significant strides in the field of oncolytic virotherapy, particularly with its lead product, Toca 511, which is designed to selectively target and destroy cancer cells while sparing healthy tissue. With a strong presence in the US and expanding operations in key global markets, Tocagen is committed to advancing its unique gene therapy platform. The company has garnered attention for its promising clinical trial results, positioning itself as a notable player in the oncology sector. Tocagen's dedication to transforming cancer treatment underscores its mission to improve patient outcomes through cutting-edge science and technology.
DitchCarbon Score
How does Tocagen Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tocagen Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tocagen Inc.'s reported carbon emissions
Tocagen Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. It is important to note that Tocagen Inc. is a merged entity, and any potential emissions data or climate commitments may be cascaded from its parent or related organisations. However, no specific sources or initiatives have been identified in this context. As the company continues to navigate its climate strategy, it remains essential for Tocagen Inc. to establish clear emissions reporting and reduction targets to align with industry standards and contribute to global climate efforts.
How Carbon Intensive is Tocagen Inc.'s Industry?
How Carbon Intensive is Tocagen Inc.'s Location?
Tocagen Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Tocagen Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
